Your professional development is critical to the care of your patients. Stay on top of the latest treatments and information with ReachMD's CME activities. Our topics span cardiology, diabetes, oncology, women's health and more. And our CME library is continuously growing, every quarter.
MACE and SGLT2 Inhibitors: Do They Have an Impact?
MACE and SGLT2 Inhibitors: Do They Have an Impact?
TRANSFORM Trial: Overview and Potential Implications
TRANSFORM Trial: Overview and Potential Implications
Clinical Practice Guidelines for Hyperlipidemia: What Are the Recommendations?
Clinical Practice Guidelines for Hyperlipidemia: What Are the Recommendations?
Treating Patients With T2D and MASLD: Is the Tide Changing?
Treating Patients With T2D and MASLD: Is the Tide Changing?
Noninvasive Tests for Clinically Significant Fibrosis: That's The Hepatologist's Job, Right?
Noninvasive Tests for Clinically Significant Fibrosis: That's The Hepatologist's Job, Right?
My Patient's At 'Low Risk' for Clinically Significant Fibrosis: What Should I Do Now?
My Patient's At 'Low Risk' for Clinically Significant Fibrosis: What Should I Do Now?
You Want Me to Perform a Liver Stiffness Test in My Clinic, Did I Hear That Right?
You Want Me to Perform a Liver Stiffness Test in My Clinic, Did I Hear That Right?
I'm Getting the Hang of This! I Have Two Patients: One At 'Indeterminate Risk' and One At 'High Risk' for Clinically Significant Fibrosis
I'm Getting the Hang of This! I Have Two Patients: One At 'Indeterminate Risk' and One At 'High Risk' for Clinically Significant Fibrosis
More Screening Recommendations? These Could Save Your Patient's Life
More Screening Recommendations? These Could Save Your Patient's Life
Improving Adherence and Persistence With Durable Anti-VEGF Therapies for nAMD
Improving Adherence and Persistence With Durable Anti-VEGF Therapies for nAMD
APPlexus Hot Topics 2024: Clinical Updates on Non-Covalent BTK Inhibitors in CLL and MCL
APPlexus Hot Topics 2024: Clinical Updates on Non-Covalent BTK Inhibitors in CLL and MCL
